Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Hypersensitivity Reaction

Free Subscription Articles published in Acta Derm Venereol Retrieve available abstracts of 94 articles: HTML format

Single Articles

April 2024
1. WEISSMANN S, Burrack N, Golan-Tripto I, Horev A, et al
   Increased Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Chronic and Severe Urticaria.
   Acta Derm Venereol. 2024;104:adv23932.
   PubMed     Abstract available
   
   
   
2. FIGUERAS I, Feito M, Garcia-Bustinduy M, Monte-Boquet E, et al
   A Qualitative Tool to Guide in the Interpretation of the Numerical Rating Scale for Pruritus Intensity in Patients with Atopic Dermatitis.
   Acta Derm Venereol. 2024;104:adv18255.
   PubMed     Abstract available
   
   
   
3. RUSSO G, Laffitte E
   Successful Therapy of Severe and Refractory Cutaneous Sarcoidosis with Baricitinib.
   Acta Derm Venereol. 2024;104:adv39970.
   PubMed    
   
   
   
4. ZHAO Q, Tominaga M, Toyama S, Komiya E, et al
   Effects of Psychological Stress on Spontaneous Itch and Mechanical Alloknesis of Atopic Dermatitis.
   Acta Derm Venereol. 2024;104:adv18685.
   PubMed     Abstract available
   
   
   March 2024
5. BAUDY A, Raison-Peyron N, Serrand C, Crepy MN, et al
   Impact of Chronic Spontaneous or Inducible Urticaria on Occupational Activity.
   Acta Derm Venereol. 2024;104:adv36122.
   PubMed     Abstract available
   
   
   
6. ULRIKSDOTTER J, Sukakul T, Bruze M, Mowitz M, et al
   Contact Allergy to Allergens in the Swedish Baseline Series Overrepresented in Diabetes Patients with Skin Reactions to Medical Devices - A Retrospective Study from Southern Sweden.
   Acta Derm Venereol. 2024;104:adv19676.
   PubMed     Abstract available
   
   
   
7. MAGEN E, Merzon E, Green I, Vinker S, et al
   Dermatological Comorbidities in Patients with Acute Urticaria.
   Acta Derm Venereol. 2024;104:adv18399.
   PubMed    
   
   
   
8. CASSALIA F, Cazzaniga S, Ofenloch R, Elsner P, et al
   Comparison of Perceptions of Skin Condition, Product Use and Allergen Reactivity Between People with Psoriasis and Controls in the European Dermato-Epidemiology Network (EDEN) Fragrance Study.
   Acta Derm Venereol. 2024;104:adv23513.
   PubMed     Abstract available
   
   
   February 2024
9. LUNDGREN S, Sonesson A
   Effect of Potassium Permanganate on Staphylococcal Isolates Derived from the Skin of Patients with Atopic Dermatitis.
   Acta Derm Venereol. 2024;104:adv18642.
   PubMed     Abstract available
   
   
   
10. AMEEN M, Alhusayen R, Brandi H, Bogelund M, et al
    Patient Preferences in the Treatment of Moderate-to-severe Atopic Dermatitis.
    Acta Derm Venereol. 2024;104:adv24339.
    PubMed     Abstract available
    
    
    
11. AKAI N, Hashimoto T, Okuzawa M, Okuno S, et al
    Lesional Infiltration of Eosinophils, Basophils, and M2 Macrophages Expressing Eotaxin-1 and Eotaxin-3 in Granuloma Faciale, but not in Erythema Elevatum Diutinum.
    Acta Derm Venereol. 2024;104:adv35401.
    PubMed    
    
    
    
12. CORK MJ, Lockshin B, Pinter A, Chen Z, et al
    Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin According to the Investigator's Global Assessment: A Post Hoc Analysis of a P
    Acta Derm Venereol. 2024;104:adv13467.
    PubMed     Abstract available
    
    
    
13. KAMPHUIS E, Boesjes CM, Loman L, Kamsteeg M, et al
    Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry.
    Acta Derm Venereol. 2024;104:adv19454.
    PubMed     Abstract available
    
    
    January 2024
14. VITTRUP I, Thein D, Thomsen SF, Egeberg A, et al
    Risk Factors that Impact Treatment with Oral Janus Kinase Inhibitors Among Adult Patients with Atopic Dermatitis: A Nationwide Registry Study.
    Acta Derm Venereol. 2024;104:adv18638.
    PubMed     Abstract available
    
    
    
15. PESQUE D, Ciudad A, Andrades E, Soto D, et al
    Solar Urticaria: An Ambispective Study in a Long-term Follow-up Cohort with Emphasis on Therapeutic Predictors and Outcomes.
    Acta Derm Venereol. 2024;104:adv25576.
    PubMed     Abstract available
    
    
    December 2023
16. MAURELLI M, Chiricozzi A, Peris K, Gisondi P, et al
    Atopic Dermatitis in the Elderly Population.
    Acta Derm Venereol. 2023;103:adv13363.
    PubMed     Abstract available
    
    
    
17. HOPKINS K, Antelmi A, Dahlin J, Olsson K, et al
    Increased Rates of Gold and Acrylate Allergy in Individuals with Fibromyalgia Tested with an Extended Dental Patch Test Series.
    Acta Derm Venereol. 2023;103:adv22336.
    PubMed     Abstract available
    
    
    
18. HAMNERIUS N, Dahlin J, Bruze M, Nilsson K, et al
    Colophonium-related Allergic Contact Dermatitis Caused by Medical Adhesive Tape Used to Prevent Skin Lesions in Soldiers.
    Acta Derm Venereol. 2023;103:adv18428.
    PubMed     Abstract available
    
    
    November 2023
19. SPRING P
    Botanical Extract Coacillium for Management of Paediatric Atopic Dermatitis: A Case Report.
    Acta Derm Venereol. 2023;103:adv13376.
    PubMed    
    
    
    
20. PEREYRA-RODRIGUEZ JJ, Baldrich ES, Ruiz-Villaverde R, Torres EB, et al
    Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus.
    Acta Derm Venereol. 2023;103:adv12314.
    PubMed     Abstract available
    
    
    
21. GIL TY, Jin BR, Park YJ, Kim HM, et al
    Effects of Magnoliae Flos on Atopic Dermatitis-Like Inflammation Evaluated via Extracellular Signal-regulated Kinase or Signal Transducers and Activators of Transcription 1/3 Signalling Pathways.
    Acta Derm Venereol. 2023;103:adv11593.
    PubMed     Abstract available
    
    
    October 2023
22. SUGIYAMA A, Murakami Y, Okamoto K, Nakano H, et al
    Nocturnal Scratching and Quality of Sleep in Children with Atopic Dermatitis.
    Acta Derm Venereol. 2023;103:adv12345.
    PubMed     Abstract available
    
    
    
23. REGUIAI Z, Becherel PA, Perrot JL, Fougerousse AC, et al
    Impact of Baricitinib on Patients' Quality of Life after One Year of Treatment for Atopic Dermatitis in Real-World Practice: Results of the Observatory of Chronic Inflammatory Skin Diseases Registry.
    Acta Derm Venereol. 2023;103:adv14153.
    PubMed     Abstract available
    
    
    
24. YASUDA KI, Ishiuji Y, Ebata T, Kogure T, et al
    Monitoring Sleep and Scratch Improves Quality of Life in Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2023;103:adv11922.
    PubMed     Abstract available
    
    
    September 2023
25. WU Z, Zhang W, Wu C, Zhou K, et al
    Hyperpigmentation in an Elderly Patient with Atopic Dermatitis: A Quiz.
    Acta Derm Venereol. 2023;103:adv13351.
    PubMed     Abstract available
    
    
    August 2023
26. KIM MJ, Kim BR, Kim SH, Chang YS, et al
    Clinical Response to Low-dose Omalizumab Treatment in Chronic Spontaneous Urticaria: A Retrospective Study of 179 Patients.
    Acta Derm Venereol. 2023;103:adv11627.
    PubMed     Abstract available
    
    
    
27. PAVLENKO D, Todurga Seven Z, Bystrom L, Markan A, et al
    Crisaborole Inhibits Itch and Pain by Preventing Neutrophil Infiltration in a Mouse Model of Atopic Dermatitis.
    Acta Derm Venereol. 2023;103:adv13382.
    PubMed     Abstract available
    
    
    
28. ZHANG J, Loman L, Oldhoff JM, Schuttelaar MLA, et al
    Beyond Anxiety and Depression: Loneliness and Psychiatric Disorders in Adults with Atopic Dermatitis.
    Acta Derm Venereol. 2023;103:adv9378.
    PubMed     Abstract available
    
    
    July 2023
29. KURKI M, Sinikumpu SP, Kiviniemi E, Jokelainen J, et al
    Validation of Diagnoses of Atopic Dermatitis in Hospital Registries: A Cross-sectional Database Study from Finland.
    Acta Derm Venereol. 2023;103:adv7266.
    PubMed    
    
    
    June 2023
30. SZABO L, Kapitany A, Somogyi O, Alhafez I, et al
    Antimicrobial Peptide Loss, Except for LL-37, is not Characteristic of Atopic Dermatitis.
    Acta Derm Venereol. 2023;103:adv9413.
    PubMed     Abstract available
    
    
    
31. KUPSA R, Gruber-Wackernagel A, Hofer A, Quehenberger F, et al
    Narrowband-ultraviolet B vs Broadband-ultraviolet B in Treatment of Chronic Pruritus: A Randomized, Single-blinded, Non-inferiority Study.
    Acta Derm Venereol. 2023;103:adv9403.
    PubMed     Abstract available
    
    
    
32. MISERY L, Seneschal J, Corgibet F, Halioua B, et al
    Impact of Atopic Dermatitis on Patients and their Partners.
    Acta Derm Venereol. 2023;103:adv5285.
    PubMed     Abstract available
    
    
    
33. GRINICH EE, Thibau IJ, Latour E, Price KN, et al
    Factors Associated with Eczema Clinical Trial Awareness, Interest, and Participation in Adults.
    Acta Derm Venereol. 2023;103:adv6520.
    PubMed     Abstract available
    
    
    May 2023
34. HARDER I, Stolzl D, Sander N, Hartmann J, et al
    Effects of Early Emollient Use in Children at High Risk of Atopic Dermatitis: A German Pilot Study.
    Acta Derm Venereol. 2023;103:adv5671.
    PubMed     Abstract available
    
    
    
35. LEE GW, Kim K, Kim SJ, Shin K, et al
    Therapeutic Effect of Dupilumab on Systemic and Vascular Inflammation in Adults with Severe Atopic Dermatitis: Feasibility Study Using 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography.
    Acta Derm Venereol. 2023;103:adv5320.
    PubMed     Abstract available
    
    
    April 2023
36. TANJI T, Watabe D, Arakawa N, Kamada H, et al
    Dual Interleukin-4/Interleukin-13 Blocker-induced Arthralgia Treated Successfully with Upadacitinib in a Patient with Atopic Dermatitis.
    Acta Derm Venereol. 2023;103:adv5326.
    PubMed    
    
    
    
37. WOO YR, Cho M, Han KD, Cho SH, et al
    Increased Risk of Dementia in Patients with Atopic Dermatitis: A Nationwide Population-Based Cohort Study.
    Acta Derm Venereol. 2023;103:adv4557.
    PubMed     Abstract available
    
    
    
38. DE BRUIN-WELLER M, Deleuran M, Biedermann T, Bissonnette R, et al
    The Treat-to-Target Project in Atopic Dermatitis: One Year On.
    Acta Derm Venereol. 2023;103:adv5382.
    PubMed     Abstract available
    
    
    
39. ALSTERHOLM M, Svedbom A, Anderson CD, Holm Sommar L, et al
    Establishment and Utility of SwedAD: A Nationwide Swedish Registry for Patients with Atopic Dermatitis Receiving Systemic Pharmacotherapy.
    Acta Derm Venereol. 2023;103:adv7312.
    PubMed     Abstract available
    
    
    
40. MANDELIN JM, Ekman A, Ruohonen ST, Korhonen L, et al
    Atopic Dermatitis Patients' Preference on Patient Self-administered Tools Used in Clinical Practice.
    Acta Derm Venereol. 2023;103:adv5261.
    PubMed    
    
    
    
41. SCHLACHTER S, Sommer R, Augustin M, Tsianakas A, et al
    A Comparative Analysis of the Predictors, Extent and Impacts of Self-stigma in Patients with Psoriasis and Atopic Dermatitis.
    Acta Derm Venereol. 2023;103:adv3962.
    PubMed     Abstract available
    
    
    March 2023
42. BELFRAGE E, Jinnestal CL, Jonsen A, Bengtsson A, et al
    Role of Mannose-binding Lectin and Association with Microbial Sensitization in a Cohort of Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2023;103:adv2405.
    PubMed     Abstract available
    
    
    
43. ALBERS CC, Metze D, Steinbrink K, Bohm M, et al
    Systemic Sarcoidosis with Cutaneous Tattoo Involvement Following COVID-19 Vaccination.
    Acta Derm Venereol. 2023;103:adv6244.
    PubMed    
    
    
    
44. KIISKI V, Ukkola-Vuoti L, Vikkula J, Ranta M, et al
    Effect of Disease Severity on Comorbid Conditions in Atopic Dermatitis: Nationwide Registry-Based Investigation in Finnish Adults.
    Acta Derm Venereol. 2023;103:adv00882.
    PubMed     Abstract available
    
    
    
45. ACHTEN R, Van der Rijst L, Piena M, Lamers H, et al
    Economic and Humanistic Burden in Paediatric Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2023;103:adv00881.
    PubMed     Abstract available
    
    
    
46. FORER E, Golan Tripto I, Bari R, Shaki D, et al
    Effect of Paediatric Atopic Dermatitis on Parental Sleep Quality.
    Acta Derm Venereol. 2023;103:adv00879.
    PubMed     Abstract available
    
    
    February 2023
47. BOESJES CM, Van der Gang LF, Zuithoff NPA, Bakker DS, et al
    Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry.
    Acta Derm Venereol. 2023;103:adv00872.
    PubMed     Abstract available
    
    
    
48. HAN Y, Woo YR, Cho SH, Lee JD, et al
    Itch and Janus Kinase Inhibitors.
    Acta Derm Venereol. 2023;103:adv00869.
    PubMed     Abstract available
    
    
    
49. LEE EM, Cho YT, Chan TC, Shen D, et al
    Economic Burden of Atopic Dermatitis in Taiwan.
    Acta Derm Venereol. 2023;103:adv00866.
    PubMed     Abstract available
    
    
    
50. TAWIL S, Irani C, Kfoury R, Abramian S, et al
    Association of Chronic Urticaria with Psychological Distress: A Multicentre Cross-sectional Study.
    Acta Derm Venereol. 2023;103:adv00865.
    PubMed     Abstract available
    
    
    January 2023
51. WEISSHAAR E, Bentz P, Apfelbacher C, Haufe E, et al
    Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany.
    Acta Derm Venereol. 2023;103:adv00854.
    PubMed     Abstract available
    
    
    
52. BARLOW R, Payyazhi G, Hogan S, Grindlay D, et al
    Suicide and Suicidality in Children and Adolescents with Chronic Skin Disorders: A Systematic Review.
    Acta Derm Venereol. 2023;103:adv00851.
    PubMed     Abstract available
    
    
    
53. LEE HJ, Lee GN, Lee JH, Han JH, et al
    Psychological Stress in Parents of Children with Atopic Dermatitis: A Cross-sectional Study from the Korea National Health and Nutrition Examination Survey.
    Acta Derm Venereol. 2023;103:adv00844.
    PubMed     Abstract available
    
    
    December 2022
54. AUGUSTIN M, Costanzo A, Pink A, Seneschal J, et al
    Real-World Treatment Patterns and Treatment Benefits among Adult Patients with Atopic Dermatitis: Results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey.
    Acta Derm Venereol. 2022;102:adv00830.
    PubMed     Abstract available
    
    
    November 2022
55. BOESJES CM, Kamphuis E, Zuithoff NPA, Bakker DS, et al
    Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry.
    Acta Derm Venereol. 2022;102:adv00820.
    PubMed     Abstract available
    
    
    
56. TIZEK L, Wecker H, Schneider S, Johansson EK, et al
    Eczema-related Web Search Data in Sweden: Investigating Search Patterns and the Influence of Weather.
    Acta Derm Venereol. 2022;102:adv00810.
    PubMed     Abstract available
    
    
    
57. KIM DC, Choi YW, Lee ES, Choi JW, et al
    No Association Between First Exposure to General Anaesthesia and Atopic Dermatitis in the Paediatric Population.
    Acta Derm Venereol. 2022 Nov 1. doi: 10.2340/actadv.v102.2738.
    PubMed     Abstract available
    
    
    October 2022
58. MERHAND S, Thenie C, Taieb C
    Family Impact of Atopic Dermatitis in Children Under Six Years of Age: A French Evaluation.
    Acta Derm Venereol. 2022 Oct 25. doi: 10.2340/actadv.v102.2562.
    PubMed    
    
    
    
59. JWO JY, Chiou K, Tsai J, Huang YC, et al
    Efficacy of Acupuncture for Treatment of Atopic Eczema and Chronic Eczema: A Systematic Review and Meta-analysis.
    Acta Derm Venereol. 2022;102:adv00791.
    PubMed    
    
    
    
60. IVERT LU, Svedbom A, Lundqvist M, Wahlgren CF, et al
    The Impact of Systemic Treatment for Atopic Dermatitis on Depressive Symptoms: A Prospective Clinical Cohort Study.
    Acta Derm Venereol. 2022 Oct 3. doi: 10.2340.
    PubMed     Abstract available
    
    
    
61. BRADLEY M, Svensson A
    Increased Knowledge-based Care is Indicated for Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2022 Oct 3. doi: 10.2340/actadv.v102.4576.
    PubMed    
    
    
    September 2022
62. LUHERNE C, Menguy S, Ferte T, Beylot-Barry M, et al
    A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sezary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma.
    Acta Derm Venereol. 2022;102:adv00773.
    PubMed     Abstract available
    
    
    August 2022
63. MOSE AP, Adwa U, Svedman C
    Allergic Contact Dermatitis to Topical Clindamycin in a Patient with Hidradenitis Suppurativa.
    Acta Derm Venereol. 2022 Aug 16. doi: 10.2340/actadv.v102.3425.
    PubMed    
    
    
    July 2022
64. JOHANSSON EK, Brenneche A, Trangbaek D, Stelmaszuk MN, et al
    Treatment Patterns among Patients with Atopic Dermatitis in Secondary Care: A National, Observational, Non-interventional, Retrospective Study in Sweden.
    Acta Derm Venereol. 2022 Jul 11. doi: 10.2340/actadv.v102.1986.
    PubMed     Abstract available
    
    
    
65. SEDEH FB, Henning MAS, Jemec GBE, Ibler KS, et al
    Comparative Efficacy and Safety of Monoclonal Antibodies and Janus Kinase Inhibitors in Moderate-to-severe Atopic Dermatitis: A Systematic Review and Meta-analysis.
    Acta Derm Venereol. 2022 Jul 11. doi: 10.2340/actadv.v102.2075.
    PubMed     Abstract available
    
    
    
66. OLESEN CM, Clausen ML, Agner T, Asplund M, et al
    Altered Maturation of the Skin Bacterial Communities in Infants with Atopic Dermatitis.
    Acta Derm Venereol. 2022 Jul 11. doi: 10.2340/actadv.v102.2275.
    PubMed     Abstract available
    
    
    June 2022
67. SANCHEZ-DIAZ M, Salazar-Nievas MC, Molina-Leyva A, Arias-Santiago S, et al
    Type D Personality Is Associated with Poorer Quality of Life in Patients with Chronic Spontaneous Urticaria: A Cross-sectional Study.
    Acta Derm Venereol. 2022;102:adv00734.
    PubMed     Abstract available
    
    
    
68. HEDEGAARD PLIESS LARSEN H, Vittrup I, Frier Ruge I, Elberling J, et al
    Severe and ChRonic ATopic Dermatitis CoHort (SCRATCH): A Danish Real-world Evidence Atopic Dermatitis Treatment Registry.
    Acta Derm Venereol. 2022 Jun 7. doi: 10.2340.
    PubMed     Abstract available
    
    
    
69. WANG M, Zheng Q, Tang S, Shen F, et al
    Purpuric Drug Eruption in a Patient with Atopic Dermatitis Treated with Dupilumab.
    Acta Derm Venereol. 2022 Jun 7. doi: 10.2340/actadv.v102.2245.
    PubMed    
    
    
    
70. SALAVA A, Rieppo R, Lauerma A, Salo V, et al
    Age-dependent Distribution of Atopic Dermatitis in Primary Care: A Nationwide Population-based Study from Finland.
    Acta Derm Venereol. 2022 Jun 7. doi: 10.2340/actadv.v102.2287.
    PubMed     Abstract available
    
    
    
71. WU L, Ali K, Qiu Y, Li M, et al
    Dupilumab-induced Acute Generalized Exanthematous Pustulosis in a 17-year-old Female Chinese Patient with Atopic Dermatitis.
    Acta Derm Venereol. 2022 Jun 7. doi: 10.2340/actadv.v102.1079.
    PubMed    
    
    
    May 2022
72. OSAWA K, Kiniwa Y, Shimosato Y, Midorikawa H, et al
    Toxic Epidermal Necrolysis Caused by Apalutamide: A Case Report of Treatment Using Etanercept with Conventional Steroid Therapy.
    Acta Derm Venereol. 2022;102:adv00723.
    PubMed    
    
    
    
73. MIYAMOTO S, Imai Y, Natsuaki M, Yamanishi K, et al
    Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab.
    Acta Derm Venereol. 2022 May 17. doi: 10.2340.
    PubMed    
    
    
    April 2022
74. GERNER T, Rasmussen Rinnov M, Halling AS, Haarup Ravn N, et al
    Differences in Occurrence, Risk Factors and Severity of Early-onset Atopic Dermatitis among Preterm and Term Children.
    Acta Derm Venereol. 2022 Apr 26. doi: 10.2340.
    PubMed     Abstract available
    
    
    
75. WOLLENBERG A, Marcoux D, Silverberg J, Aoki V, et al
    Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2022 Apr 8. doi: 10.2340.
    PubMed     Abstract available
    
    
    
76. THOMSEN SF, Pritzier EC, Anderson CD, Juvik S, et al
    Treatment Patterns and Clinical Outcomes of Chronic Urticaria: Two-year Follow-up Results from the Scandinavian AWARE Study.
    Acta Derm Venereol. 2022;102:adv00689.
    PubMed     Abstract available
    
    
    March 2022
77. LUNDIN S, Bergstrom A, Wahlgren CF, Johansson EK, et al
    Living with Atopic Dermatitis as a Young Adult in Relation to Health-related Quality of Life and Healthcare Contacts: A Population-based Study.
    Acta Derm Venereol. 2022 Mar 21. doi: 10.2340.
    PubMed     Abstract available
    
    
    
78. CREPY MN, Bensefa-Colas L, Aubin F, Simon M, et al
    Vocational Guidance for Young Atopic Dermatitis Patients: A Survey of Physicians' Opinions and Practices.
    Acta Derm Venereol. 2022 Mar 1. doi: 10.2340.
    PubMed     Abstract available
    
    
    February 2022
79. BATINAC T, Hlaca N, Simetic L, Valkovic F, et al
    Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma.
    Acta Derm Venereol. 2022;102:adv00650.
    PubMed    
    
    
    January 2022
80. ACHTEN RE, Van Luijk C, Van der Rijst L, Bakker D, et al
    Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2022 Jan 31. doi: 10.2340/actadv.v101.1128.
    PubMed     Abstract available
    
    
    
81. KIYOHARA T, Fukudome T, Kamio Y, Koike Y, et al
    Clinical Course of Atopic Dermatitis in an Adult with Amyotrophic Lateral Sclerosis: Etiologic Implications of Voluntary Movements and Dermatitis Severity.
    Acta Derm Venereol. 2022 Jan 28. doi: 10.2340/actadv.v101.1121.
    PubMed    
    
    
    
82. ROGNER D, Biedermann T, Lauffer F
    Treatment of Atopic Dermatitis with Baricitinib: First Real-life Experience.
    Acta Derm Venereol. 2022 Jan 27. doi: 10.2340/actadv.v101.1088.
    PubMed    
    
    
    
83. TAYEFI M, Bradley M, Neijber A, Fastberg A, et al
    Chronic Urticaria: A Swedish Registry-based Cohort Study on Population, Comorbidities and Treatment Characteristics.
    Acta Derm Venereol. 2022;102:adv00624.
    PubMed     Abstract available
    
    
    December 2021
84. HUPPOP F, Dahnhardt-Pfeiffer S, Folster-Holst R
    Characterization of Classical Flexural and Nummular Forms of Atopic Dermatitis in Childhood with Regard to Anamnestic, Clinical and Epidermal Barrier Aspects.
    Acta Derm Venereol. 2021 Dec 22. doi: 10.2340.
    PubMed     Abstract available
    
    
    
85. QIU Y, Ali K, Lou H, Shan J, et al
    Successful Treatment of Atopic Dermatitis with Dupilumab in a Patient with Non-Hodgkin's Lymphoma.
    Acta Derm Venereol. 2021 Dec 14. doi: 10.2340.
    PubMed    
    
    
    
86. JU Y, Li M, Lu X, Zhao C, et al
    Skin Picking in Atopic Dermatitis and Psoriasis Patients: A Single-centre Cross-sectional Study in China.
    Acta Derm Venereol. 2021 Dec 14. doi: 10.2340.
    PubMed    
    
    
    November 2021
87. STAUMONT D, Taieb C, Merhand S, Shourick J, et al
    The Atopic Dermatitis Control Tool, A High-Performance Tool for Optimal Support.
    Acta Derm Venereol. 2021 Nov 29. doi: 10.2340.
    PubMed     Abstract available
    
    
    
88. MITRI F, Toberer F, Enk AH, Hartmann M, et al
    Acute Generalized Exanthematous Pustulosis in Close Temporal Association with mRNA-1273 Vaccine.
    Acta Derm Venereol. 2021;101:adv00596.
    PubMed    
    
    
    
89. NYMAN GSA, Gimenez-Arnau AM, Grigaitiene J, Malinauskiene L, et al
    Patch Testing with Propolis of Different Geographical Origins in a Baseline Series.
    Acta Derm Venereol. 2021;101:adv00591.
    PubMed     Abstract available
    
    
    October 2021
90. KWIATKOWSKA D, Reich A
    Role of Mast Cells in the Pathogenesis of Pruritus in Mastocytosis.
    Acta Derm Venereol. 2021;101:adv00583.
    PubMed     Abstract available
    
    
    
91. NAKAHARA T, Kido-Nakahara M, Onozuka D, Sakai S, et al
    Efficacy of Dupilumab for Atopic Dermatitis According to Clinical Course and Clinical Findings: A Multicentre Retrospective Study.
    Acta Derm Venereol. 2021 Oct 28. doi: 10.2340.
    PubMed    
    
    
    
92. TAKEOKA S, Kamata M, Yokoi I, Takehara A, et al
    Rapid Enlargement of Vitiligo Vulgaris after Initiation of Dupilumab for Atopic Dermatitis: A Case Report.
    Acta Derm Venereol. 2021;101:adv00581.
    PubMed    
    
    
    
93. SILVERBERG JI, Simpson EL, Boguniewicz M, De Bruin-Weller MS, et al
    Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis.
    Acta Derm Venereol. 2021 Oct 7. doi: 10.2340.
    PubMed     Abstract available
    
    
    September 2021
94. WEISS D, Nordhorn I, Tizek L, Werfel T, et al
    Prescription Behaviour and Barriers to Prescription of Biologicals for Treatment of Chronic Inflammatory Skin Diseases in Dermatological Practice in Two German Federal States.
    Acta Derm Venereol. 2021;101:adv00560.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge.